A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury

  • Post author:
  • Post category:

Translational Candidate The therapeutic candidate is a central nervous system tissue-derived GMP line developed under DISC2-10753 with an established GMP qualified seed bank. Area of Impact The target is chronic…

Continue ReadingA human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury

CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia

  • Post author:
  • Post category:

Translational Candidate CD72-targeting chimeric antigen receptor (CAR) T cells incorporating fully synthetic nanobodies Area of Impact Pediatric B-cell acute lymphoblastic leukemia refractory to currently available treatments without other potentially curative…

Continue ReadingCD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia

Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma

  • Post author:
  • Post category:

Translational Candidate Human T cells transduced with a lentiviral vector encoding anti-EGFRvIII synNotch-primed anti-EphA2/IL-13Rα2 chimeric antigen receptor. Area of Impact Glioblastoma is the most common malignant brain tumor, affecting approximately…

Continue ReadingDevelopment of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma

Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia

  • Post author:
  • Post category:

Translational Candidate Human induced pluripotent stem cell-derived glial enriched progenitors Area of Impact Vascular dementia and white matter stroke, addressing a current bottleneck of poor scale up for existing cell…

Continue ReadingClinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia